Biomarkers: evaluation of clinical utility in surveillance and early diagnosis for hepatocellular carcinoma-Reference-Cited by-同舟云学术

Biomarkers: evaluation of clinical utility in surveillance and early diagnosis for hepatocellular carcinoma

Published:2016-07-13 Issue:sup245 Volume:76 Page:S70-S76
ISSN:0036-5513
Container-title:Scandinavian Journal of Clinical and Laboratory Investigation
language:en
Short-container-title:Scandinavian Journal of Clinical and Laboratory Investigation

Author:

Song Peipei,Tang Qi,Feng Xiaobin,Tang Wei

Publisher

Informa UK Limited

Subject

Clinical Biochemistry,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.1080/00365513.2016.1210328

Reference55 articles.

1. Hepatocellular carcinoma in cirrhosis: Incidence and risk factors

2. WHO. GLOBOCAN 2012: Estimated Cancer Incidence, Mortality and Prevalence Worldwide in 2012. http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx (accessed December 1, 2015).

3. Recent advances in surgical treatment of hepatocellular carcinoma

4. Liver transplantation and autoimmune hepatitis

5. Liver transplantation for hepatocellular carcinoma

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Three-Dimensional Structure of Novel Liver Cancer Biomarker Liver Cancer-Specific Serine Protease Inhibitor Kazal (LC-SPIK) and Its Performance in Clinical Diagnosis of Hepatocellular Carcinoma (HCC);Diagnostics;2024-03-29

2. Validation of combined AFP, AFP-L3, and PIVKA II for diagnosis and monitoring of hepatocellular carcinoma in Chinese patients;Heliyon;2023-11

3. Biomarkers for Hepatocellular Carcinoma: From Origin to Clinical Diagnosis;Biomedicines;2023-06-28

4. Diagnosis of Hepatocellular Carcinoma through Telehealth: A Unique Case Report;JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH;2023

5. An innovative electrochemical immunosensor based on nanobody heptamer and AuNPs@ZIF-8 nanocomposites as support for the detection of alpha fetoprotein in serum;Microchemical Journal;2022-08